Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Photochemistry offers Alzheimer's and multiple sclerosis (MS) diagnosis:

This article was originally published in Clinica

Executive Summary

A photochemical technique developed by University of Kentucky researchers may allow early diagnosis of Alzheimer's disease and multiple sclerosis (MS). Speaking at the American Association of Pharmaceutical Scientists annual meeting at Miami Beach earlier this month Dr Boyd Haley said the technique could detect altered protein interactions in spinal fluid from Alzheimer's patients and unique proteins in fluid from MS sufferers. Neither are detectable by traditional protein detection methods, he said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094128

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel